CD8A and systemic sclerosis: For this reason, we have assessed the anti-proliferative effects of ASCs, isolated from subcutaneous fat of SLE (SLE/ASCs) and SSc (SSc/ASCs) patients, on CD4+ and CD8+ T cells using ASCs originating from healthy donors (HD/ASCs) as the reference cell lines.